2021
DOI: 10.30844/i40m_21-1_s27-31
|View full text |Cite
|
Sign up to set email alerts
|

Corona: Katalysator für Digitalisierung und Transparenz?

Abstract: Die Corona-Krise hatte einen unübersehbaren Einfluss auf die Beschaffungssituation in den globalen Lieferketten, an den sich die Unternehmen schnell anpassen mussten. Die Auswirkungen verdeutlichen, dass sich die Unternehmen zur Reduzierung der Risiken mit der Struktur und der Transparenz in den Lieferketten beschäftigen müssen. Im folgenden Beitrag wird untersucht, über welche Kenntnisse die Akteure verfügen und wie sie diese durch die Digitalisierung verbessern wollen. Die Ergebnisse belegen, dass die Untern… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
4
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 8 publications
(4 citation statements)
references
References 7 publications
0
4
0
Order By: Relevance
“…Last but not least, the COVID-19 pandemic has impressively shown how necessary it is to make business processes more resilient. Schnelle et al [20] demonstrate how digitalization can play a part in this. The results of their study show that transparency and the exchange of data are more limited in SMEs than in large-scale enterprises.…”
Section: Approachmentioning
confidence: 99%
“…Last but not least, the COVID-19 pandemic has impressively shown how necessary it is to make business processes more resilient. Schnelle et al [20] demonstrate how digitalization can play a part in this. The results of their study show that transparency and the exchange of data are more limited in SMEs than in large-scale enterprises.…”
Section: Approachmentioning
confidence: 99%
“…The collapse in the production of these semi-finished goods in East Asia, mainly in China and India, created bottlenecks with cascading impacts across supply chains, ultimately causing declines in the supply of finished medical products all over the world. To prevent another crisis on such a scale should COVID-19 strike back again or in the case of any future pandemics, four main strategies are considered (Shao et al 2021;Flach, Aichele, & Braml, 2020;Bunde, 2021;Schnelle, Schöpper, & Kersten, 2021;Lang, 2021): a. reshoring or backshoring1 or nearshoring2 the production of products that are crucial for national security, including medical products; b. diversifying (finding alternative) suppliers; c. giving up on the use of just-in-time deliveries and increasing companies' storage capacities; d. improving the process of managing supply chains by a greater reliance on digital technology.…”
Section: Literature Reviewmentioning
confidence: 99%
“…Some of them concerned its impact on GSCs in the context of IR 4.0. These include: Van Zijverden, Kluge, Jovanovic [65]; Magablech [66]; Javorcik [67]; Görg, Mösle [68]; Kilic, Marin [69]; Abel-Koch, Ullrich [70]; Bunde [71]; Schnelle, Schöpper, Kersten [72]; Elia et al [73]; Fu [74]; Antras [75].…”
mentioning
confidence: 99%
“…The dire effects of COVID-19 sparked a lively discussion in scientific and economic circles about the need to change the current production paradigm based on the fragmentation of GSCs and the tendency in many companies to make appropriate changes with a view to reducing the risks it poses. A number of options are being considered, of which the following will undoubtedly have the greatest impact on the transformation of GSCs [68][69][70][71][72][73][74][75][86][87][88] •…”
mentioning
confidence: 99%